Moneycontrol PRO
Swing Trading 101
Swing Trading 101

Comedian Aishwarya Mohanraj says she took Mounjaro for weight loss, but are GLP-1 therapies for everyone?

Comedian Aishwarya Mohanraj revealed in a recent YouTube post that she took Mounjaro (tirzepatide) when despite following strict diet and exercising regularly, she was unable to shed some weight over the years. To know more about GLP-1 therapies, read on.

February 13, 2026 / 08:20 IST
Snapshot AI
  • Aishwarya Mohanraj's Mounjaro use sparks obesity drug debate
  • GLP-1 drugs aid weight loss but aren't suitable for everyone
  • GLP-1s require medical evaluation and lifestyle changes

Comedian Aishwarya Mohanraj's claim to using Mounjaro for weight loss has led to renewed discussions of obesity and GLP-1 injections. Such drugs can help control appetite and blood sugar, though they are not appropriate for everyone. Doctors suggest sho is eligible and what precautions are needed If you decide to take it?

When public figures are open about their health journeys, it can lead to broader discussions. Comedian Aishwarya Mohanraj revealed in a recent YouTube post that she took Mounjaro (tirzepatide) when despite following strict diet and exercising regularly, she was unable to shed some weight over the years. Her frank confession has refocused attention on obesity, now considered to be a chronic metabolic disease rather than simply a cosmetic problem.

Also read: 38-year-old physician reverses fatty liver, high bp, high cholesterol, type 2 diabetes, drops 56 kilos in 18 months

Weight gain is not just a matter of willpower for many. Hormones, genetics, metabolism, lifestyle, sleep and stress all play complicated parts. With the advance of science, drugs such as GLP-1 are effective in treating obesity and type 2 diabetes. These drugs are thought to mimic natural gut hormones that help regulate blood sugar and appetite, so people feel full more quickly and eat less.

“GLP-1 therapies when used in the right setting can be transformative,” says Dr. Arun Kumar, Consultant Endocrinologist and Metabolic Health Specialist at Vinayak Global—but that doesn’t mean they are for everyone. It is very important to know who a right candidate for them and who should avoid them along with what precautions need to be followed.

What Are GLP-1 Therapies?

GLP-1 (glucagon-like peptide-1) therapies are drugs that act very much like the natural hormone released in the gut after eating. This hormone controls blood sugar, slows the rate at which the stomach empties and tells the brain there is no need for more food.

Medications such as semaglutide and tirzepatide (Mounjaro) are associated with weight loss of more than 10 percent over a few months when added to lifestyle changes. There also seems to be an improved blood sugar level and a decreased risk for metabolic problems among many patients.

Who Should Consider GLP-1 Injections?

GLP-1-based treatments may be suitable for

  • Persons with a BMI of 30 or greater (obesity).
  • People who have weight-related medical conditions, such as type 2 diabetes, high blood pressure, sleep apnea or high cholesterol and have a BMI of 27% or higher.

Patients with type 2 diabetes who need improved blood sugar levels and to lose weight.

Individuals that have failed to achieve and maintain weight loss with supervised diet and exercise alone.

Who Should Avoid GLP-1 Therapies?

You may not be able to use GLP-1 injection if you have:

  • Patients who have personal or familial medullary thyroid cancer.
  • Those who have the Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
  • Clients with serious GI conditions like gastroparesis.
  • Pregnant or breastfeeding women.

Also read: Doctor says these 3 medicines can save a heart attack patient

  • People looking for purely cosmetic weight loss in the absence of a medical need.
  • Please remember that these drugs require a prescription, and thus medical examination.

Pre-Treatment and Treatment Measures

Medical Evaluation

A thorough discussion of medical history, intake meds and labs is required.

Watch for Side Effects: The most common side effects are upset stomach, diarrhea, and vomiting but these often ease after a few weeks.

Lifestyle Commitment

GLP-1 drugs are not magic bullets. Keeping weight off long term will depend on healthy eating habits and regular physical activity.

Routine Checks

Continual observation for safety, and assessment of improvement is required.

FAQs on Mounjaro for weight loss

Q. What is Mounjaro?

Mounjaro is an injectable prescription medication containing tirzepatide. It was originally approved for type 2 diabetes and is now also prescribed for weight management in eligible individuals.

Q. How does Mounjaro help with weight loss?

It works on GLP-1 and GIP hormones, which regulate appetite, blood sugar and digestion. This helps reduce hunger and increase feelings of fullness.

Q. Who is eligible to take Mounjaro for weight loss?

Typically, adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions like diabetes or hypertension, under medical supervision.

Q. Is Mounjaro the same as other GLP-1 drugs?

It is similar but works on two hormone pathways (GLP-1 and GIP), which may enhance its effects compared to single-hormone therapies.

Q. How is it taken?

It is given as a once-weekly subcutaneous injection.

Disclaimer: This article, including health and fitness advice, only provides generic information. Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis

Nivedita is a Delhi-based journalist who writes on health, fashion, lifestyle and entertainment. Views expressed are personal.
first published: Feb 13, 2026 08:19 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347